TrialThe American journal of gastroenterology2019

A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation.

Darren M Brenner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.